First Financial Bank Trust Division Lowers Position in Colgate-Palmolive (NYSE:CL)

First Financial Bank Trust Division reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 6.9% in the 4th quarter, HoldingsChannel reports. The firm owned 11,395 shares of the company’s stock after selling 842 shares during the period. First Financial Bank Trust Division’s holdings in Colgate-Palmolive were worth $1,036,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Advisor OS LLC grew its stake in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after purchasing an additional 101 shares during the period. D Orazio & Associates Inc. grew its position in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after buying an additional 108 shares during the period. Fiducient Advisors LLC grew its position in Colgate-Palmolive by 5.2% during the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after buying an additional 110 shares during the period. Wealthspire Advisors LLC increased its holdings in Colgate-Palmolive by 3.0% in the second quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock valued at $374,000 after buying an additional 111 shares in the last quarter. Finally, Sequoia Financial Advisors LLC boosted its stake in shares of Colgate-Palmolive by 0.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after acquiring an additional 113 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Down 0.4 %

NYSE:CL traded down $0.36 during trading hours on Thursday, hitting $90.55. The stock had a trading volume of 3,118,276 shares, compared to its average volume of 4,373,890. The company has a market cap of $73.98 billion, a PE ratio of 25.95, a price-to-earnings-growth ratio of 3.31 and a beta of 0.43. The business has a 50 day simple moving average of $93.64 and a two-hundred day simple moving average of $98.52. Colgate-Palmolive has a 1-year low of $79.52 and a 1-year high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.21%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CL. JPMorgan Chase & Co. raised their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price target for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Wednesday. UBS Group lifted their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their price target for the company from $107.00 to $109.00 in a research report on Monday, September 9th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.